ABSTRACT
Introduction
As Kidney transplantation offers patients with end-stage renal disease the greatest potential for increased longevity and enhanced quality of life. It is important to have data regarding urological complications in live related renal transplant patients and their management. Despite improvements in surgical and diagnostic techniques, surgical complications (SCs) following kidney transplantation remain an important clinical problem that may increase morbidity, hospitalization and cost. The data on urological complications of renal transplantation in live donor kidney transplant is limited.
The purpose of this study was to document a retrospective analysis of urological complications following living related kidney transplants in order to study the overall incidence of these complications and their management.
Patients and Methods
This is a retrospective study of one hundred and four consecutive live related kidney transplants performed at urology department, Alexandria university between June 1990 and December 2012. Themedical and surgical records of all recipients were collected and analyzed. Preoperative extensive work up for both the donor and recipient was performed including HLA typing, cross matching and CT angiogram for evaluation of donor kidney vasculature. All of our patients were first time transplant. All grafts were placed in right iliac fossa.
Immunosuppression protocol using the combination of Cyclosporine, Azathioprine and corticosteroids was applied for all patients except one who was induced with simulect due to mildly positive panel reactive antibodies. The graft renal vein was anastomosed end to side with external iliac vein. The renal artery was anastomosed end to end with native internal iliac artery in 102 patients and two were end to side fashion with native external iliac artery.
Ureterovesiacl anastomosis was established by modified Lich
Gregoire technique of extra vesical ureteroneocystostomy. JJ stent was placed in sixty four patients as we adopted non-stented anastomosis in the first forty patients. Redivac drain and Foley catheter were removed on 5th, 7th post-operative day respectively. On 10th post-operative day, the patients were discharged after measurement of the blood level of immunosupperission drugs. After four weeks, JJ stent was removed under culture based antibiotic coverage.
Results
Seventy three (70.2%) were male and thirty one (29.8%) were females. with a mean age of 30.8 years. (Range, 11-55 years).
Mean serum creatinine on post-operative day 7 was 1.2 mg/dl (0.9-2.1) which was achieved in sixty six patients (63.4%) while 85 recipients (81.7%) had the same mean serum creatinine on day 30.
Fourteen urological complications were observed in our patients, constituting an overall incidence of 13.4%. There were ten patients with urinary leakage and four cases of obstructive uropathy, Four out of ten patients presented with urine leakage underwent kidney transplant surgery from 1990 to 2000 while the remaining six patients underwent surgery from 2000 to 2012
The leakage of urine started with in twenty four hours of surgery in the first four patients while in the other six patients the leakage started on the 4th post-operative day. Re-exploration for the first three patients had revealed leakage from uretroneocystostomy which were initially done without a JJ stent and were manged by reimplantation of the ureter over a JJ stent in. The fourth patient had a short donor ureter was managed during transplantation by Boari flap. On re-exploration leakage at the anastomsis site observed which was repaired.
From 2000 to 2012, the six patients presented with urine leakage started on the 4th post-operative day. All of them had stented uretero vesical anastomosis. PCN was inserted under fluoroscopic guidance in all patients resulted in stoppage of the leakage. Four weeks later patients underwent cystoscopic stent removal and combined (antegrade and retrograde) contrast study which revealed neither extravasation nor stricture. PCN was removed days after. Only one patient developed ureterovesical stricture after six months who was managed by ballon dilatation and JJ stent.
Four patients presented with obstructive uropathy in the form of two patients with ureterovesical stricture two weeks post JJ removal and managed by PCN and antegrade JJ stent insertion, the third one presented with upper ureteric stricture mostly due to impaired vascularity of the donor ureter who was managed by PCN and antegrade LASER endouretertomy. Unfortunately, his baseline creatinine level became high (3.6 mg/dl) and accordingly, the decision was taken to exchange JJ stent every year. The last patient presented with large lymphocele (7*8cm)compressing on the upper ureter causing moderate hydroureteronephrosis with renal impairment(serum cret=2.8 mg/dl).the patient prepared for PCN and laparoscopic marspulization of lymphocele.after stabilization of the graft function(serum cre=1.1 mg/dl),antegrade nephrogram revealed no ureteric obstruction then PCN was closed for three days to monitor the temparture and leucocytic count and degree of right iliac fossa pain.Three days later PCN was removed and patient is doing well since that. 
Discussion
Urological complications following renal transplantation cause significant morbidity and/or graft loss. The two important factors influencing the success of ureterovesivcal anastomosis are the vascularity of the donor ureter, which may be compromised during the donor nephrectomy and by handling during transplantation. Vascular compromise produces ischemia that may affect both proximal and distal parts of ureter [1] [2] [3] [4] . Two of our patients had impaired graft function, they returned to temporary dialysis and were at risk of graft loss due to impaired vascular supply of the ureter, one had proximal stricture and the other had distal stricture at Boari flap site.
The incidence of ureteric complications in current literature is between 6-14% [5] [6] [7] . In our series overall urological complications rate was 13.4% which is comparable to other series. A study carried out by A Sirvastava et al [8] , reported 7.7% complication rate with non-stented and 2.0% with stented ureteral anastomosis.
However, the complication rate in our series is slightly higher than A Sirvastava (11.3, 4.2% respectively), it may be due to a smaller number of patients in our series.
It has been our policy to avoid dissection in the triangle between renal hilum, ureter and lower pole of the kidney to avoid damage to ureteral vasculature. As the ureter receives most of the blood from renal vessels, we use the minimum required length of the ureter.
Other factor which might result in decreasing the complications rate in our series was the routine use of stented extravesical ureteroneocystostomy, which has been shown to be associated with a lower incidence of urological complications in other studies as well [9] . Most of the urological complications occurred early after renal transplantation (ten out of fourteen complications occurred within the first post-operative week), this corroborates with similar finding in other studies [9, 10] .
Role of routine ureteric stenting in the kidney transplant setting is debatable in literature. A prospective randomized study evaluated the effect of ureteric stenting by Kumar concluded that routine placement of stent was cost effective and almost eliminate urological complications [11] .
Many studies have shown that routine use of JJ stents in kidney transplantation significantly reduced the number of early urinary leakage and obstructive uropathy [12, 13] . Same is our experience with JJ stent.
The possibility of stent related complications like urinary tract infection, encrustation, stone formation, can be avoided by using biocompatible stents for minimal possible duration. In our study,stenting for four weeks avoided complications without compromising benefits [14] .
Conclusion
The technique of stented extravesical ureteronecystostomy has associated with a low rate of urological complications in our series.
